Cornell researchers have developed a stable, multi-target vaccine offering long-lasting protection against COVID-19 and influenza, with promising results in mice. Cornell University researchers have developed a new vaccine platform designed to offer stronger, longer-lasting protection against bot
scitechdaily.com